Position in HLN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$13,500
-$2,986 QoQ
Shares Held
1,447
-12.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#460
of 639 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hilton Head Capital Partners, LLC holds $195,796 across 9 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,756 | $93,373 | |
| 2 | LQDA |
Liquidia Corp
|
500 | $39,865 | |
| 3 | VTRS |
Viatris Inc
|
1,185 | $18,817 | |
| 4 | TLRY |
Tilray Brands, Inc.
|
3,766 | $16,909 | |
| 5 | HLN |
Haleon plc
This page
|
1,447 | $13,500 | |
| 6 | ZTS |
Zoetis Inc.
|
125 | $8,982 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
163 | $2,612 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
50 | $1,733 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,500 | 1,447 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $16,486 | 1,647 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $16,651 | 1,647 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||